Cogent Biosciences, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
Cogent Biosciences, Inc. (COGT) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 100.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2026-08-10
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2026-03-31 was 100.00%, a 0.00% change year-over-year.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2025-03-31 was 100.00%, a 0.00% change year-over-year.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2024-03-31 was 100.00%, a 0.00% change year-over-year.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for the quarter ending 2023-03-31 was 100.00%, a 0.00% change year-over-year.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2025 was 100.00%, a 0.00% change from fiscal 2024.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2024 was 100.00%, a 0.00% change from fiscal 2023.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 100.00%, a 0.00% change from fiscal 2022.
- Cogent Biosciences, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 100.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 3 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 6 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 9 month | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|---|---|---|
| 2026-06-30 | 100.00% 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | 100.00% 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 100.00% 10-K · filed 2026-02-17 | |||
| 2025-09-30 | 100.00% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 100.00% 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | 100.00% 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | 100.00% 10-K · filed 2025-02-25 | |||
| 2024-09-30 | 100.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 100.00% 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | 100.00% 10-K · filed 2024-02-26 | |||
| 2023-09-30 | 100.00% 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 100.00% 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | 100.00% 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 100.00% 10-K · filed 2023-03-14 | |||
| 2022-09-30 | 100.00% 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 100.00% 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 100.00% 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 100.00% 10-K · filed 2022-03-15 | |||
| 2021-09-30 | 100.00% 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 100.00% 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | 100.00% 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |